Five phase 3 trials presented at ESMO 2026 showed new options in small cell lung, bladder, prostate, KRAS G12C lung and ...
For people with lung or pancreatic cancer driven by changes in the KRAS gene, research presented at the 2026 European Society ...
Adding Imdelltra (tarlatamab) to Imfinzi (durvalumab) maintenance therapy helped people with extensive-stage small cell lung ...
Researchers are exploring new options for patients with relapsed or refractory hairy cell leukemia, including chimeric ...
For patients with hairy cell leukemia whose cancer returns after multiple treatments, researchers are investigating whether ...
The FDA previously approved FoundationOne CDx, which uses a tumor tissue sample, and FoundationOne Liquid CDx, which uses a ...
Many people keep working during cancer treatment, return to work afterward or take time off to care for a loved one with ...
The FDA grants traditional approval to Keytruda and Keytruda Qlex for TMB-H solid tumors, updating the threshold to at least ...
Diagnosed with bone cancer at 14, college setter Gabby Orlet shares how volleyball, honesty and her family carried her ...
The study enrolled 25 patients with high-grade bladder cancer that had come back after earlier BCG treatment. Their median ...
After 19 years of survivorship, one cancer survivor reflects on life's changing seasons, managing scan anxiety and finding ...
Patients with locally advanced breast cancer whose lymph nodes appear cancer-free after chemotherapy given before surgery may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results